Literature DB >> 10551878

Opposite translational control of GLUT1 and GLUT4 glucose transporter mRNAs in response to insulin. Role of mammalian target of rapamycin, protein kinase b, and phosphatidylinositol 3-kinase in GLUT1 mRNA translation.

C Taha1, Z Liu, J Jin, H Al-Hasani, N Sonenberg, A Klip.   

Abstract

Prolonged exposure of 3T3-L1 adipocytes to insulin increases GLUT1 protein content while diminishing GLUT4. These changes arise in part from changes in mRNA transcription. Here we examined whether there are also specific effects of insulin on GLUT1 and GLUT4 mRNA translation. Insulin enhanced association of GLUT1 mRNA with polyribosomes and decreased association with monosomes, suggesting increased translation. Conversely, insulin arrested the majority of GLUT4 transcripts in monosomes. Insulin inactivates the translational suppressor eukaryotic initiation factor 4E-binding protein-1 (4E-BP1) through the mammalian target of rapamycin (mTOR). Hence, we examined the effect of rapamycin on GLUT1 mRNA translation and protein expression. Rapamycin abrogated the insulin-mediated increase in GLUT1 protein synthesis through partial inhibition of GLUT1 mRNA translation and partial inhibition of the rise in GLUT1 mRNA. 4E-BP1 inhibited GLUT1 mRNA translation in vitro. Because phosphatidylinositol 3-kinase (PI3K) and protein kinase B (PKB), in concert with mTOR, inactivate 4E-BP1, we explored their role in GLUT1 protein expression. Cotransfection of cytomegalovirus promoter-driven, hemagglutinin epitope-tagged GLUT1 with dominant inhibitory mutants of PI3K or PKB inhibited the insulin-elicited increase in hemagglutinin-tagged GLUT1 protein. These results unravel the opposite effects of insulin on GLUT1 and GLUT4 mRNA translation. Increased GLUT1 mRNA translation appears to occur via the PI3K/PKB/mTOR/4E-BP1 cascade.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10551878     DOI: 10.1074/jbc.274.46.33085

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Signaling in control of cell growth and metabolism.

Authors:  Patrick S Ward; Craig B Thompson
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-07-01       Impact factor: 10.005

2.  SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice.

Authors:  Cuiying Xiao; Hyun-Seok Kim; Tyler Lahusen; Rui-Hong Wang; Xiaoling Xu; Oksana Gavrilova; William Jou; David Gius; Chu-Xia Deng
Journal:  J Biol Chem       Date:  2010-09-16       Impact factor: 5.157

Review 3.  Common toxicities of mammalian target of rapamycin inhibitors.

Authors:  Scott A Soefje; Anand Karnad; Andrew J Brenner
Journal:  Target Oncol       Date:  2011-04-16       Impact factor: 4.493

4.  Akt2 modulates glucose availability and downstream apoptotic pathways during development.

Authors:  Penny J Jensen; Laura B Gunter; Mary O Carayannopoulos
Journal:  J Biol Chem       Date:  2010-03-31       Impact factor: 5.157

5.  Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats.

Authors:  N Deblon; L Bourgoin; C Veyrat-Durebex; M Peyrou; M Vinciguerra; A Caillon; C Maeder; M Fournier; X Montet; F Rohner-Jeanrenaud; M Foti
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

6.  Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma.

Authors:  Graham M Strub; Andrew L Kirsh; Mark E Whipple; Winston P Kuo; Rachel B Keller; Raj P Kapur; Mark W Majesky; Jonathan A Perkins
Journal:  JCI Insight       Date:  2016-09-08

7.  Hyperpolarized MRI Visualizes Warburg Effects and Predicts Treatment Response to mTOR Inhibitors in Patient-Derived ccRCC Xenograft Models.

Authors:  Yiyu Dong; Roozbeh Eskandari; Chelsea Ray; Kristin L Granlund; Lidia Dos Santos-Cunha; Vesselin Z Miloushev; Sui Seng Tee; Sangmoo Jeong; Omer Aras; Ying-Bei Chen; Emily H Cheng; James J Hsieh; Kayvan R Keshari
Journal:  Cancer Res       Date:  2018-11-20       Impact factor: 12.701

8.  Insulin receptor substrate-2 regulates aerobic glycolysis in mouse mammary tumor cells via glucose transporter 1.

Authors:  Shannon L Pankratz; Ernest Y Tan; Yumiko Fine; Arthur M Mercurio; Leslie M Shaw
Journal:  J Biol Chem       Date:  2008-12-04       Impact factor: 5.157

Review 9.  Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy.

Authors:  Ruirong Yuan; Andrea Kay; William J Berg; David Lebwohl
Journal:  J Hematol Oncol       Date:  2009-10-27       Impact factor: 17.388

10.  Topical insulin accelerates cutaneous wound healing in insulin-resistant diabetic rats.

Authors:  Tianyi Yu; Min Gao; Peilang Yang; Qing Pei; Dan Liu; Di Wang; Xiong Zhang; Yan Liu
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.